IMDX vs IMA: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

IMDX has stronger fundamentals based on our AI analysis.

IMDX
Insight Molecular Diagnostics Inc.
STRONG SELL
88%
Confidence
VS
IMA
ImageneBio, Inc.
STRONG SELL
85%
Confidence

IMDX vs IMA Fundamental Comparison

Metric IMDX IMA
Revenue $4.1M $800,000.0
Net Income $-50.2M $-45.3M
Net Margin -1,238.5% -5,668.6%
ROE N/A -34.1%
ROA -195.0% -29.6%
Current Ratio 1.27x 12.49x
Debt/Equity N/A 0.00x
EPS $-1.65 $-9.64

Green = Better metric | Red = Weaker metric

View Full IMDX Analysis →
View Full IMA Analysis →

You Might Also Compare

IMDX vs AAPL IMA vs MSFT IMDX vs GOOGL IMA vs AMZN

IMDX vs IMA: Frequently Asked Questions

Is IMDX or IMA a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), IMDX has stronger fundamentals. IMDX is rated STRONG SELL (88% confidence) while IMA is rated STRONG SELL (85% confidence). This is not investment advice.

How does IMDX compare to IMA fundamentally?

Insight Molecular Diagnostics Inc. has ROE of N/A vs ImageneBio, Inc.'s -34.1%. Net margins are -1,238.5% vs -5,668.6% respectively.

Which stock pays higher dividends, IMDX or IMA?

IMDX has a dividend yield of N/A or no dividend while IMA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in IMDX or IMA for long term?

For long-term investing, consider that IMDX has STRONG SELL rating with 88% confidence, while IMA has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about IMDX vs IMA?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMDX vs IMA, the AI consensus favors IMDX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.